Clinical trial
Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure
NCT04049045 is registered in ClinicalTrials.gov with Christian Schulze as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure
- Lead sponsor
- Christian Schulze
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 29, 2019
- Completion date
- June 29, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute decompensated heart failure